首页> 外文OA文献 >Stereotactic Ablative Radiotherapy (SABR) May Reduce the Need for Long-Term Androgen Deprivation Therapy (ADT) in Patients with Oligometastatic Prostate Cancer

【2h】

Stereotactic Ablative Radiotherapy (SABR) May Reduce the Need for Long-Term Androgen Deprivation Therapy (ADT) in Patients with Oligometastatic Prostate Cancer

机译：立体定向烧蚀放疗（SABR）可以减少对寡核症患者的长期抗剥夺疗法（ADT）的需要

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
R. Dagan; C.M. Bryant; J.E. Bates; A.N. De Leo; A. Oester; C.G. Morris; P. Okunieff;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Stereotactic Ablative Radiotherapy (SABR) May Reduce the Need for Long-Term Androgen Deprivation Therapy (ADT) in Patients with Oligometastatic Prostate Cancer [J] . Dagan R., Bryant C. M., Bates J. E., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：立体定向烧蚀放疗（SABR）可以减少对寡核症患者的长期抗剥夺疗法（ADT）的需要
2. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial [J] . Palma David A., Olson Robert, Harrow Stephen, The Lancet . 2019,第10185期

机译：寡核瘤癌患者的立体定向烧蚀疗法与护理姑息治疗（SABR-COMET）：随机，第2期，开放标签试验
3. To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer [J] . Shultz David Benjamin, Diehn Maximilian, Loo Billy W. Jr. Seminars in radiation oncology . 2015,第2期

机译：去SABR还是不去SABR？立体定向消融放疗在早期阶段，低水平转移性或少进展性非小细胞肺癌中的适应症和禁忌症。
4. Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR) [C] . S Devpura, M S Siddiqui, D Chen, ICCR . 2014

机译：肺癌治疗计划剂量计算的建议（SABR）治疗肺癌治疗计划（SABR）
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer [O] . Charlotte L. Deijen, Gerbert L. Vrijenhoek, Eva E. Schaake, 2021

机译：PSMA-11-PET / CT与胆碱PET / CT引导oneTOMOTOTACTACTAL癌症患者的雄激素剥夺治疗患者的立体定向烧蚀疗法
7. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial [O] . D.A. Palma, R.A. Olson, S. Harrow, 2020

机译：定向型烧蚀放疗寡粒子癌的综合治疗：SABR-COMET随机试验的长期结果
8. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer. [R] . Loo, B. J. W. 2017

机译：肿瘤缺氧的EF5 pET：早期肺癌立体定向烧蚀放疗（saBR）反应的预测成像生物标志物。

Stereotactic Ablative Radiotherapy (SABR) May Reduce the Need for Long-Term Androgen Deprivation Therapy (ADT) in Patients with Oligometastatic Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅